Larsen and Toubro Infotech Ltd up by 15.93 percent | Espresso

EspressoLogy

Espresso shot of the day – Larsen and Toubro Infotech Ltd up by 15.93 percent

October 19, 2021
Espresso shot of the day – Larsen and Toubro Infotech Ltd up by 15.93 percent

LARSEN & TOUBRO INFOTECH LTD. 6847.80 (+15.93 %) BSE – INE214T01019 | 19TH  OCTOBER 2021

Larsen and Toubro Infotech (LTI) is a global technology consulting and digital solutions company helping more than 435 clients succeed in a converging world. With operations in 31 countries, they go the extra mile for our clients and accelerate their digital transformation with LTI’s Mosaic platform enabling their mobile, social, analytics, IoT and cloud journeys. Each day, their team of more than 36,000 LTItes enable their clients to improve the effectiveness of their business and technology operations and deliver value to their customers, employees and shareholders.

Recent Drivers

  • On Oct 19, 2021, Larsen & Toubro reported quarterly net profit at Rs. 496.80 crores in September 2021 up 15.59% from Rs. 429.80 crores in September 2020.
  • On Oct 19, 2021, Larsen & Toubro reported net sales at Rs 3,426.70 crores in September 2021 up 22.41% from Rs. 2,799.40 crores in September 2020.
  • On Oct 18, 2021, the board of directors at their meeting declared an interim dividend for the financial year 2021- 22, of Rs 15.00/- per equity share. The same shall be paid to equity shareholders of the Company whose names appear in the Register of Members of Company or in records of Depositories as beneficial owners of equity shares as on Tuesday, October 26, 2021, which is record date fixed for the said purpose. The interim dividend will be paid on or before November 16, 2021.
  • On Oct 18, 2021, the Company approved the allotment of 19,250 equity shares of face value of Rs. 1/- each under the Employee Stock Option Scheme 2015 of the Company.
  • On Sept 28, 2021, Larsen & Toubro Infotech entered in a strategic partnership with eClinicalHealth Limited to accelerate digital innovation in R&D Clinical Trials Management process for patient centric drug development. The partnership will help clients decentralize clinical trials setting new benchmarks of excellence in clinical research space.
  • On Aug 26, 2021, the Company has approved the allotment of 86,393 equity shares of face value of Rs. 1/- each under the Employee Stock Option Scheme 2015 of the Company, on August 26, 2021.
  • On July 29, 2021, Larsen & Toubro Infotech has been named Winner of the PTC Partner Network Awards in the category of Transformation in Manufacturing Operations. LTI also emerged as a finalist in two additional categories of Most Impact in Digital Transformation at Scale and Trailblazer/Innovation Project.
  • On July 8, 2021, Larsen & Toubro Infotech completed acquisition of Cuelogic Technologies, a digital engineering and outsourced product development company.
 (Sources: Moneycontrol, BSE India, LNTinfotech.com, Business Standard)


Technical Force*

  • S&P BSE 200 month till date gain up by 0.71%
  • Traded on all time High Value 7010.00
  • 3 months avg. NSE volume: 4,02,064
  • Quantity traded: 2,16,108 Deliverable quantity: 63,345 (29.31%)
  • Stock price has jumped more than 140% from one-year low level: 2828.10 (Oct 29, 2020)
  • Daily RSI (14) is in Overbought territory today
  • 52-week-high: 7010.00 | 52-week-low:  2828.10

Key Pivot  (Yearly)

R4

R3

R2

R1

PP /FIB PP

S1

S2

S3

S4

Pivot Point

-

 6992.03

5345.02

4501.63

2854.62

2011.23

364.22

-

    -

Fibonacci Pivot

5345.02

4393.68

3805.95

3427.41

2845.62

2281.82

1903.28

1315..55

364.22


Today’s Close

6847.80

SMA

BSE

10 DAY

5971.12

20 DAY

5916.13

50 DAY

5485.51

200 DAY

4392.64


Some Key Ratios (Source: BSE)

Market Cap: 1,19,955.55 crores

PE: 59

OPM%: 22.21

ROE%: 27.29

Promoters holding%: 74.09

Prev. Close: 5907.00

*Chart And Technical Force data taken from the Binge desktop app.

The scope and usability of this information/data is time-sensitive and market-based, and as such the same may become outdated for the investment decisions of clients, for which Sharekhan comtrade bears no responsibility. References to securities do not constitute a recommendation to buy, sell or hold such securities. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document and should consult his own advisors to determine the merits and risks of such an investment. Sharekhan Comtrade Private Limited is under no obligation to update the information in this document from time-to-time.




Chandresh Khona
by Chandresh Khona

Product Offerings Head

A teacher, writer, travel buff and now Espresso's Product Offerings Head. Ten years here has allowed me to lead the digital team at Sharekhan. My true passion lies in stock market charts.